Categories
News Review from The World Web Times

BRAF-Targeted Drug Approved for Pediatric Low-Grade Glioma


Brain tumors, including low-grade gliomas, can also cause growth delays, Dr. Kilburn said. So the FIREFLY-1 participants will be followed to see if normal growth resumes at the end of tovorafenib treatment and whether the treatment has long-term effects on growth.